Full-Time

QC Specialist I

QC Analytics, Cell Therapy, 1st shift, Wednesday to Saturday

Posted on 8/17/2024

ElevateBio

ElevateBio

501-1,000 employees

Biotechnology for cell and gene therapies

Biotechnology
Healthcare

Mid

Waltham, MA, USA

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor’s, or Master’s, degree in a technical discipline (Biology/Chemistry/Microbiology or related field) with at least 3 years of related experience (1 year for Master’s degree).
  • Significant experience in the following methodologies: qPCR/ddPCR, immunoassays, cell-based assays including Flow Cytometry, HPLC, AUC, and cIEF.
  • Experience drafting test methods and associated qualifications/validations.
  • Excellent organizational skills and attention to detail.
  • Ability to work independently and communicate/collaborate with scientific/technical personnel.
  • Significant knowledge of GMPs, SOPs, and Quality System processes; experience in a GMP QC laboratory setting is preferred.
  • Experience working in cell and gene therapy manufacturing environment is a plus.
  • Experience working with electronic systems (LIMS, CMMS, QMS, ERP) is a plus.
Responsibilities
  • Work cross-functionally with QC Analytical Development to qualify and transfer developed assays.
  • Draft and review qualification/validation methods as well as associated test methods/SOPs and reports.
  • Perform routine analytical tests, analyze results, and record data/report in LIMS.
  • Collaborate with other QC functions to ensure all testing is completed within established timelines.
  • Investigate and review analytical testing excursions, including deviations, CAPAs and OOSs.
  • Assist in the training of laboratory staff.

ElevateBio focuses on biotechnology, specifically in the cell and gene therapy market. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies. The company stands out from competitors by offering an integrated ecosystem that combines manufacturing, technology, and therapeutic development, enabling them to advance a wide range of therapies. Their goal is to remove barriers to scientific breakthroughs and commercialize effective cell and gene therapies.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

3%

1 year growth

-4%

2 year growth

-1%
Simplify Jobs

Simplify's Take

What believers are saying

  • ElevateBio's $401 million Series D funding boosts its growth and development capabilities.
  • Partnerships with Novo Nordisk and others expand ElevateBio's market reach and expertise.
  • The trend towards personalized medicine aligns with ElevateBio's integrated therapy ecosystem.

What critics are saying

  • New biomanufacturing facilities like BioForge increase competition in cell and gene therapy.
  • Reliance on large funding rounds may pose financial sustainability challenges for ElevateBio.
  • Dependence on strategic partnerships could impact revenue if collaborations fail.

What makes ElevateBio unique

  • ElevateBio integrates R&D and manufacturing for efficient cell and gene therapy commercialization.
  • The company leverages proprietary technologies like iPSC and gene editing for therapy development.
  • ElevateBio's partnerships with innovators enhance its portfolio of life-transforming medicines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE